病毒過濾市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、技術、最終用途、地區和競爭格局分類，2021-2031年

全球病毒過濾市場預計將從 2025 年的 57.8 億美元成長到 2031 年的 95.2 億美元，複合年成長率為 8.67%。

該市場涵蓋專門用於去除生物製藥下游製程（包括單株抗體和重組蛋白）中病毒污染物的小型化技術。推動這一市場成長的關鍵因素是國際監管機構實施的嚴格安全法規，以及不斷擴大的生物製藥研發管線，這些製劑需要檢驗的病毒去除流程以確保患者安全。此外，該行業穩健的財務狀況也為持續的製程開發和生產規模擴大提供了支持。

根據歐洲製藥廠商協會聯合會（EFPIA）的數據，2024年歐洲以研發為基礎的製藥業在研發領域的投資金額約為550億歐元。如此巨額的投資表明，越來越多的候選藥物需要可靠的病毒安全防護措施。然而，可能阻礙市場成長的主要障礙包括一次性奈米過濾膜的高昂營運成本以及薄膜污染等技術難題。這些因素可能會給致力於實現成本效益生產的製造商帶來沉重的預算負擔。

市場促進因素

生物製藥和生物相似藥生產行業的快速成長是全球病毒過濾市場的主要驅動力。隨著製藥公司擴大產能以滿足全球對單株抗體和重組蛋白日益成長的需求，對包括病毒過濾在內的可靠下游加工技術的需求也變得愈發重要。這種擴張的特點是建造大規模生產設施和引進高容量生物反應器。例如，三星生物製劑在2025年1月發布的「2024會計年度第四季及全年財務業績」中報告稱，隨著其第五家工廠的運作，其生物製藥總產能預計將達到78.4萬升。產能的顯著提升直接得益於病毒過濾模組的廣泛應用，以確保最終生物製藥原料藥的安全性和純度。

此外，生物製藥研發管線投入的增加刺激了市場需求，擴大了需要去除病毒的治療方法範圍。資金籌措的激增推動了細胞療法和基因療法等複雜生物製藥的開發，這些療法需要特殊的過濾策略來去除潛在的病毒污染物，同時又不影響產品產量。這種對創新的關注正在擴展臨床管線，導致正在進行下游驗證的分子數量增加。根據國際藥品製造商協會聯合會（IFPMA）於2024年12月發布的《2024年事實與數據》報告，截至2024年10月，全球有超過12,700種藥物處於不同的研發階段。此外，大量資金正用於現代化改造現有設施，以適應這些新的管線。例如，諾和諾德公司在2024年宣布，將投資41億美元在北卡羅來納州克萊頓市興建第二座填充和包裝生產設施。

市場挑戰

除了一次性奈米過濾濾膜的高昂運作成本外，膜污染這項技術難題也是全球病毒過濾市場成長的主要障礙。過濾系統過早污染會導致薄膜頻繁更換，從而擾亂生產流程。此類中斷不僅會增加材料成本，還會延誤生產進度，使得採用這些病毒去除技術成為生物製藥公司本已難以維持價格競爭力的又一沉重經濟負擔。

鑑於將治療產品推向市場需要巨額資金，這種財務壓力尤其嚴峻。根據國際藥品製造商協會聯合會（IFPMA）估計，到2024年，開發一種新藥的平均成本將達到26億美元。由於前期投資如此龐大，製造商面臨著在下游製程中盡可能降低成本的巨大壓力。因此，昂貴且易受污染的過濾設備造成的經濟效益低下，可能會阻礙潛在買家，限制產品推廣規模，並直接阻礙市場進一步擴張。

市場趨勢

將過濾整合到連續生物製程中，正透過以穩態下游單元取代傳統的間歇式操作，改變全球病毒過濾市場。這種轉變減少了對中間儲存的需求，縮小了設施面積，並直接滿足了業界對更有效率製程策略的需求。透過將病毒過濾模組與上游層析法步驟連續連接，製造商可以實現更高的體積生產率，並檢驗長期運作穩定性。例如，在2024年11月舉辦的題為「最佳化連續生產中的病毒去除」的網路研討會上，藥明生物報告了其成功實施的連續病毒過濾系統，該系統運作超過200小時而未發生病毒突破，證明了此類流程在商業規模下確保病毒安全性的可行性。

同時，下游製程一體化解決方案正日益受到策略關注，技術供應商積極投資開發整合多個純化階段的綜合平台。這一趨勢的驅動力在於市場對預先驗證的端到端解決方案的需求，這些解決方案能夠減輕複雜生物製藥開發的負擔。領先的供應商正在大力投資創新中心，以建立這些綜合生產架構。例如，默克集團（Merck KGaA）於2024年4月發布題為「投資超過3億歐元建設新的生命科學研究中心」的公告，宣布將在達姆施塔特投資超過3億歐元建設一座專門用於探索下一代抗體和其他生物技術產品生產解決方案的設施。這凸顯了以供應商主導的整合製程創新趨勢。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球病毒過濾市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 產品類別（耗材{試劑盒和試劑，其他}，設備（過濾系統，層析法系統），服務）
  • 依技術（過濾、層析法）
  • 透過申請（生物製藥和生物技術公司、受託研究機構、學術機構和研究機構等）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美病毒過濾市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲病毒過濾市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區病毒過濾市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲病毒過濾市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美病毒過濾市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球病毒過濾市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Merck KGaA
• Danaher Corporation
• Sartorius AG
• Thermo Fisher Scientific Inc.
• GE Healthcare Technologies, Inc.
• Charles River Laboratories
• Asahi Kasei Medical Co., Ltd.
• WuXi AppTec
• Lonza Group AG
• Clean Biologics

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Virus Filtration Market is projected to expand from USD 5.78 Billion in 2025 to USD 9.52 Billion by 2031, registering a CAGR of 8.67%. This market consists of specialized size-exclusion technologies engineered to remove viral contaminants during the downstream processing of biopharmaceuticals, including monoclonal antibodies and recombinant proteins. The primary factors driving this growth are the stringent safety regulations enforced by international authorities and the growing pipeline of biologic drugs that require validated viral clearance steps to guarantee patient safety, a demand further supported by the sector's strong financial health which facilitates continuous process development and manufacturing scale-up.

According to the European Federation of Pharmaceutical Industries and Associations, the research-based pharmaceutical industry invested approximately €55,000 million in R&D across Europe in 2024. This significant financial commitment emphasizes the increasing volume of therapeutic candidates that require dependable viral safety measures. However, a major obstacle that could hinder market growth is the high operational cost linked to single-use nanofiltration membranes and the technical challenge of membrane fouling, which can burden the budgets of manufacturers aiming for cost-effective production.

Market Driver

The rapid growth of the biologics and biosimilars manufacturing sector serves as a key catalyst for the Global Virus Filtration Market. As pharmaceutical companies expand their production capabilities to address the rising global demand for monoclonal antibodies and recombinant proteins, the need for robust downstream processing technologies, including virus filtration, becomes increasingly critical. This expansion is marked by the construction of large-scale manufacturing facilities and the adoption of high-capacity bioreactors; for instance, Samsung Biologics reported in its 'Fourth Quarter and Fiscal Year 2024 Financial Results' in January 2025 that its total biomanufacturing capacity is projected to reach 784,000 liters with the upcoming activation of Plant 5. Such substantial increases in volumetric capacity are directly associated with a greater utilization of virus filtration modules to ensure the safety and purity of the final biologic drug substance.

Furthermore, increasing R&D investments in biopharmaceutical pipelines are stimulating market demand by broadening the range of therapeutic modalities that require viral clearance. This surge in funding advances the development of complex biologics, such as cell and gene therapies, which demand specialized filtration strategies to eliminate potential viral contaminants without sacrificing product yield. This focus on innovation expands the clinical pipeline, thereby increasing the number of molecules undergoing downstream processing validation; according to the International Federation of Pharmaceutical Manufacturers and Associations' 'Facts & Figures 2024' report from December 2024, over 12,700 medicines were in various stages of development globally by October 2024. Additionally, significant capital is being directed toward facility modernization to accommodate these new pipelines, as evidenced by Novo Nordisk's 2024 announcement of a $4.1 billion investment to build a second fill and finish manufacturing facility in Clayton, North Carolina.

Market Challenge

The substantial operational expenditure associated with single-use nanofiltration membranes, combined with the technical difficulties of membrane fouling, creates a significant barrier to the growth of the Global Virus Filtration Market. When filtration systems undergo premature fouling, it requires frequent membrane replacements and causes interruptions in the manufacturing workflow. These disruptions not only increase material costs but also delay production timelines, making the adoption of these viral clearance technologies financially burdensome for biopharmaceutical companies that are already striving to maintain competitive pricing.

This financial pressure is particularly severe given the immense capital required to bring therapeutic products to market. According to the International Federation of Pharmaceutical Manufacturers & Associations, the estimated average cost to develop a new medicine was USD 2.6 billion in 2024. With such massive upfront investments at stake, manufacturers are under intense pressure to minimize downstream processing expenses. Consequently, the economic inefficiencies caused by expensive, fouling-prone filtration units can deter potential buyers or limit the scale of adoption, directly impeding broader market expansion.

Market Trends

The incorporation of filtration into continuous bioprocessing workflows is reshaping the Global Virus Filtration Market by replacing traditional batch-mode operations with steady-state downstream units. This shift reduces the need for intermediate holding tanks and decreases facility footprints, directly meeting the industry's need for intensified processing strategies. By continuously connecting virus filtration modules with preceding chromatography steps, manufacturers can achieve higher volumetric productivity and validate long-term operational stability; for example, WuXi Biologics noted in their November 2024 webinar, 'Optimizing Viral Clearance in Continuous Manufacturing', that they successfully implemented continuous virus filtration systems operating for over 200 hours without viral breakthrough, demonstrating the viability of these workflows for commercial-scale viral safety.

At the same time, there is a strategic focus on integrated downstream processing solutions, with technology vendors actively funding the development of holistic platforms that unify multiple purification stages. This trend is driven by the market's demand for pre-validated, end-to-end solutions that reduce the process development burden for complex biologic modalities. Major suppliers are directing substantial capital toward innovation hubs to engineer these comprehensive manufacturing architectures; for instance, Merck KGaA announced in April 2024, under 'Invests More Than € 300 Million in New Life Science Research Center', a commitment of over €300 million to construct a facility in Darmstadt dedicated to researching next-generation solutions for manufacturing antibodies and other biotechnological products, underscoring the shift toward vendor-led integrated process innovation.

Key Market Players

• Merck KGaA
• Danaher Corporation
• Sartorius AG
• Thermo Fisher Scientific Inc.
• GE Healthcare Technologies, Inc.
• Charles River Laboratories
• Asahi Kasei Medical Co., Ltd.
• WuXi AppTec
• Lonza Group AG
• Clean Biologics

Report Scope

In this report, the Global Virus Filtration Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Virus Filtration Market, By Product

• Consumables
• Instruments
• Services

Virus Filtration Market, By Technology

• Filtration
• Chromatography

Virus Filtration Market, By End Use

• Biopharmaceutical & biotechnology companies
• Contract research organizations
• Academic institutes & research laboratories
• Others

Virus Filtration Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Virus Filtration Market.

Available Customizations:

Global Virus Filtration Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Virus Filtration Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Consumables {Kits and reagents, Others}, Instruments (Filtration systems, Chromatography systems), Services)
  • 5.2.2. By Technology (Filtration, Chromatography)
  • 5.2.3. By End Use (Biopharmaceutical & biotechnology companies, Contract research organizations, Academic institutes & research laboratories, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Virus Filtration Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Virus Filtration Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Virus Filtration Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Virus Filtration Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By End Use

7. Europe Virus Filtration Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Virus Filtration Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Virus Filtration Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Virus Filtration Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Virus Filtration Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Virus Filtration Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By End Use

8. Asia Pacific Virus Filtration Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Virus Filtration Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Virus Filtration Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Virus Filtration Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Virus Filtration Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Virus Filtration Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Virus Filtration Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Virus Filtration Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Virus Filtration Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Virus Filtration Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By End Use

10. South America Virus Filtration Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technology
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Virus Filtration Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Virus Filtration Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Virus Filtration Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Virus Filtration Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Merck KGaA
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Danaher Corporation
• 15.3. Sartorius AG
• 15.4. Thermo Fisher Scientific Inc.
• 15.5. GE Healthcare Technologies, Inc.
• 15.6. Charles River Laboratories
• 15.7. Asahi Kasei Medical Co., Ltd.
• 15.8. WuXi AppTec
• 15.9. Lonza Group AG
• 15.10. Clean Biologics

16. Strategic Recommendations

17. About Us & Disclaimer